# SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat

> **NCT02589158** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 16 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Evotaz
- **DRUG:** Rezolsta

## Key facts

- **NCT ID:** NCT02589158
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02589158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02589158, "SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02589158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*